RNA Therapy Clinical Trials Market

RNA Therapy Clinical Trials Market is segmented by Product (Messenger RNA Therapies, Small Interfering RNA Therapies, Antisense Oligonucleotide Therapies, RNA Aptamer Therapies, RNA Editing And Gene Regulation Therapies), Application (Oncology, Infectious Diseases, Rare Genetic Disorders, Cardiovascular Diseases, Neurological Disorders), Trial Phase (Phase I Trials, Phase II Trials, Phase III Trials, Phase IV Trials), and Region, with forecasts covering the period from 2026 to 2036.